Mirum pharmaceuticals enters agreement to acquire bile acid product portfolio for the treatment of rare liver diseases from travere therapeutics

Foster city, calif. & san diego--(business wire)-- #liverdisease--mirum pharmaceuticals enters agreement to acquire bile acid product portfolio for the treatment of rare liver diseases from travere therapeutics.

TVTX Ratings Summary

TVTX Quant Ranking